Descovy (emtricitabine/tenofovir alafenamide) is a brand-name oral tablet prescribed for preexposure prophylaxis (PrEP) in certain people at risk of developing HIV. Descovy also treats HIV in certain ...
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Gilead Sciences Canada, Inc. (Gilead Canada) today announced that Health Canada has granted a Notice of Compliance (NOC) for DESCOVY® (emtricitabine 200 mg and ...
George Froehle, PA, a primary care clinician at CentraCare in rural St. Cloud, Minnesota, has been prescribing the HIV prevention pill tenofovir disoproxil fumarate plus emtracitabine (TDF/FTC) since ...
Descovy (emtricitabine/tenofovir alafenamide) is a brand-name tablet prescribed for treating HIV. Descovy works by blocking HIV from multiplying and spreading in the body. Nausea was the more common ...
The federal Food and Drug Administration October 3 approved a new daily PrEP pill that could offer a safer option for some individuals at risk for HIV, but the indication does not cover everyone who ...
A new HIV prevention option works well for gay and bisexual men and transgender women and should be approved by the Food and Drug Administration for these populations, according to an expert advisory ...
A federal jury Tuesday handed Gilead Sciences Inc. a victory against the U.S. government in a long, contentious battle over control of three patents for two important HIV-fighting drugs. The verdict ...
It’s unfair and frankly stupid that we have to worry about other illnesses while a pandemic rages its way through our country. But life goes on, and so do all the other things that threaten ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results